Multi-omic machine learning predictor of breast cancer therapy response
2021 · Nature · 600 citations
https://doi.org/10.1038/s41586-021-04278-5
J
Jeremy Thomas
NHS Lothian(GB)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
144
Papers
5.1K
Citations
36
h-index
79
i10-index
Jeremy Thomas is an academic researcher from NHS Lothian. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & HER2/EGFR in Cancer Research. The author has an h-index of 36, co-authored 123 publications.
ORCID: 0000-0002-4652-610XPapers by this author
worksAddressing overtreatment of screen detected DCIS; the LORIS trial
2015 · European Journal of Cancer · 365 citations
https://doi.org/10.1016/j.ejca.2015.07.017
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
2009 · Annals of Oncology · 184 citations
https://doi.org/10.1093/annonc/mdp427
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial
2015 · The Lancet Oncology · 133 citations
https://doi.org/10.1016/s1470-2045(15)70137-3
Mammostrat®as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy
2010 · Breast Cancer Research · 118 citations
https://doi.org/10.1186/bcr2604
Type 1 Receptor Tyrosine Kinase Profiles Identify Patients With Enhanced Benefit From Anthracyclines in the BR9601 Adjuvant Breast Cancer Chemotherapy Trial
2008 · Journal of Clinical Oncology · 96 citations
https://doi.org/10.1200/jco.2007.14.6597
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat